Investigative Ophthalmology & Visual Science Cover Image for Volume 64, Issue 8
June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Best Disease: Review of reported causing mutations, genotype-phenotype correlation, and prevalence analysis in the Israeli population
Author Affiliations & Notes
  • Samer Khateb
    Hadassah University Medical Center, Jerusalem, Jerusalem, Israel
  • Ygal Rotenstreich
    Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel
  • Nitza Goldenberg-Cohen
    Ophthalmology, Bnai Zion Medical Center, Haifa, Haifa, Israel
  • Libe Gradstein
    Ophthalmology, Soroka Medical Center, Beer Sheva, Southern, Israel
  • Boris Rosin
    Ophthalmology, UPMC, Pittsburgh, Pennsylvania, United States
  • Itay Chowers
    Hadassah University Medical Center, Jerusalem, Jerusalem, Israel
  • Rina Leibu
    Ophthalmology, Rambam Health Care Campus, Haifa, Haifa, Israel
  • Hadas Newman
    Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Tel Aviv, Israel
  • Miriam Ehrenberg
    Ophthalmology, Rabin Medical Center, Petah Tikva, Central, Israel
  • Tamar Ben-Yosef
    Genetics, Technion Israel Institute of Technology The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Haifa, Israel
  • Eran Pras
    Ophthalmology, Shamir Medical Center Assaf Harofeh, Tzrifin, Central, Israel
  • Dina Zur
    Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Tel Aviv, Israel
  • Eyal Banin
    Hadassah University Medical Center, Jerusalem, Jerusalem, Israel
  • Dror Sharon
    Hadassah University Medical Center, Jerusalem, Jerusalem, Israel
  • Avigail Beryozkin
    Hadassah University Medical Center, Jerusalem, Jerusalem, Israel
  • Footnotes
    Commercial Relationships   Samer Khateb None; Ygal Rotenstreich None; Nitza Goldenberg-Cohen None; Libe Gradstein None; Boris Rosin None; Itay Chowers None; Rina Leibu None; Hadas Newman None; Miriam Ehrenberg None; Tamar Ben-Yosef None; Eran Pras None; Dina Zur None; Eyal Banin None; Dror Sharon None; Avigail Beryozkin None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1528. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Samer Khateb, Ygal Rotenstreich, Nitza Goldenberg-Cohen, Libe Gradstein, Boris Rosin, Itay Chowers, Rina Leibu, Hadas Newman, Miriam Ehrenberg, Tamar Ben-Yosef, Eran Pras, Dina Zur, Eyal Banin, Dror Sharon, Avigail Beryozkin; Best Disease: Review of reported causing mutations, genotype-phenotype correlation, and prevalence analysis in the Israeli population. Invest. Ophthalmol. Vis. Sci. 2023;64(8):1528.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To review all reported Best disease causing mutations, perform genotype-phenotype correlation, and estimate disease prevalence in the Israeli population.

Methods : Medical records of patients with Best disease, adult-onset vitelliform macular dystrophy (AVMD), and bestrophinopathy were collected over the last 20 years from most tertiary medical centers in Israel. Clinical data included eye examination, fundoscopy, visual acuity, refraction, electroretinography (ERG), electrooculography (EOG) and optical-coherence tomography images. Mutation analysis on patients was performed by candidate gene analysis and whole exome sequencing. Mutation data was collected from Pubmed, HGMD, LOVD and were analyzed using manually written code on R-studio and QSIG. Disease prevalence was calculated in the Israeli population with 9.656 million residents.

Results : A total of 116 Israeli subjects were diagnosed with Best disease (87 patients), AVMD (16) or AR bestrophinopathy (13), according to fundoscopic findings, ERG and EOG. Based on the estimated population size of 9.656 million citizens, the minimal prevalence of Best disease in Israel is 1:83,333, with higher prevalence in the Arab-Muslim population (1:59,172) compared to the Jewish population (1:90,909). The genetic cause of the disease was identified in 83 patients (72%), mainly with autosomal dominant inheritance due to BEST1 (21 mutations), PRPF2 (4 mutations), and IMPG2 (1 mutation) genes.
In addition, we collected information on all reported BEST1 mutations and analyzed their distribution along bestrophin. The analysis revealed conserved regions in 3 out of the 4 trans-membrane domains and in the intracellular domains only in areas within close proximity to the trans-membrane domains. Those conserved areas include 78% of the dominant missense mutations (p-value < 0.001). No correlation was identified between amino acid conservation and the age of onset.

Conclusions : We showed here that the prevalence of Best disease in Israel is similar to the one reported in Sweden (1.5:100,000) and lower than the reported one in USA, and the prevalence of AVMD is much lower than was reported previously in USA (1:7,400-1:8,200 ). The conserved amino acids located mainly in the transmembrane domains and intracellular regions are extremely crucial for normal protein folding and function.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×